My mission is simple, to make you money.

I'm here to level the playing field for all investors.

There's always a homework somewhere,

and I promise to help you find it.

Man money starts now.

Hey, I'm Kramer.

Welcome to a very special San Francisco edition of Bad Money.

Welcome to Cramerger.

I'll be able to make friends, I'm just trying to make you some money.

My job is just entertained by the Edgegate context.

Call me 1-80743CBC or tweet me atchammer.

Now this market is caught in a titanic battle

between chat gp-G-P-1s. And today the winner was chat g-G-P-T with the Dowdipping 158 points, S&B declining 0.15% and the tech-laid

NASDAQ advancing 0.09%. Of course there's a lot more of this market than just

tech versus healthcare. Right now you can learn a lot from chat, geepee, the way many people first learned

about gender of AI, and you can tell from my interviews in San Francisco that the

revolutionary GLP-1s for weight loss and diabetes are driving a ton of R&D from so many different drug companies

that know they have to make these drugs because this could be the biggest category of drugs in history.

We came out here this week, can't be out with the

J.P. Morgan health care covers to find out the latest and greatest in health care only

discover that nearly everybody in the industry either has a GOP-1 business or they're trying to develop a better weight loss drug or

helping to make sure you get the drug or playing defense against this whole class of

...